Form 4 Filing for Edesa Biotech, Inc. - Officer Stock Grant

Peter J. Weiler, Chief Financial Officer of Edesa Biotech, Inc., was granted 64,609 common shares on May 27, 2026. This grant, valued at $0.00 per share, was issued under the Issuer's 2019 Equity Incentive Compensation Plan. The restricted share units are set to vest monthly over thirty-six months, commencing on the grant date. Following this transaction, Mr. Weiler holds 129,609 shares. This filing is classified as an officer transaction related to equity compensation.